FDA Week - 09/06/2019

Pew: Expect Business As Usual After FDA Antibiotic Head Departs

By David Roza / August 30, 2019 at 6:31 PM
The senior director of health programs at The Pew Charitable Trusts doesn’t expect a dramatic upheaval at FDA’s Office of Antimicrobial Products after its longtime director, Ed Cox, departed on Sunday (Aug. 25) to become vice president of regulatory affairs at drug maker Regeneron. Though Cox was an excellent contact for stakeholders in the antibiotic space, Allan Coukell said the former director leaves behind a well-versed staff that should be able to pick up where he left off. “Ed has...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.